A
Adnexi offers KOL discovery mapping capabilities for biopharma companies focused on gene therapy and rare diseases, enabling precise identification of key opinion leaders in these specialized fields. This technology enhances collaboration and accelerates the development of life-saving treatments by connecting companies with influential experts and stakeholders.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Adnexi offers KOL discovery mapping capabilities for biopharma companies focused on gene therapy and rare diseases, enabling precise identification of key opinion leaders in these specialized fields. This technology enhances collaboration and accelerates the development of life-saving treatments by connecting companies with influential experts and stakeholders.